论文部分内容阅读
作者应用流行性腮腺炎皮试抗原(MSTA)的初步结果表明MSTA可在皮肤中对天花免疫产生局部干扰,也可在多发性病损患者中溶解皮肤疣,包括足跖疣。这提示MSTA (Lilly)可用以治疗其他的病毒性肿瘤。MSTA由杀死后的流腮病毒制备。一个进行性喉喘鸣的两岁小儿,诊断为多发性喉乳头状瘤。为使呼吸道通畅作了气管切开和肿瘤刮除,因此并发了单侧气胸。4周后表现有病损复发而需再作喉镜检查。作者决定试用MSTA。此患儿在16个月时曾用过活流腮病毒疫苗进行免
Preliminary results from Mumps Mitera Antigen Test (MSTA) show that MSTA can cause local interference with smallpox immunization in the skin and that it can also dissolve cutaneous warts, including plantar warts, in patients with multiple lesions. This suggests that MSTA (Lilly) can be used to treat other viral tumors. MSTA is prepared from killed mumps virus. A two-year-old child with progressive throat wheeze is diagnosed with multiple laryngeal papilloma. To make the airway open tracheotomy and tumor curettage, so complicated with unilateral pneumothorax. 4 weeks after the performance of the recurrence of lesions need to be laryngoscopy again. The author decided to try MSTA. The child had been vaccinated with mumps virus at 16 months